net/publication/49652740
Pyoderma gangrenosum
CITATIONS READS
20 603
5 authors, including:
Amit Kansal
Kansal Arthritis and Rheumatology Centre
15 PUBLICATIONS 104 CITATIONS
SEE PROFILE
Some of the authors of this publication are also working on these related projects:
All content following this page was uploaded by Amit Kansal on 28 May 2014.
Pyoderma Gangrenosum
Renu Saigal***, Yadvinder Singh**, Manoop Mittal**, Amit Kansal**, Hari Ram Maharia**
Abstract
Pyoderma gangrenosum (PG) is an idiopathic, ulcerative, noninfective chronic inflammatory skin disorder
of unknown etiology. It is associated with systemic medical illness in 50% of cases like inflammatory bowel
disease, systemic arthritis, haematological diseases and malignancies. Characteristic lesions begin as pustule or
vesiculopustule and progresses to an ulcer or deep erosion with violaceous overhanging or undermined borders.
Diagnosis of pyoderma gangrenosum is clinical and depends on exclusion of other causes of cutaneous
ulceration. The management of PG is treatment of underlying systemic medical illness and judicious use of
immunosuppressants. Association of PG with these medical illnesses and treatment with immunosuppressants
make the clinical utility for internists, gastroenterologists, haematologists and rheumatologists.
(a) (b)
Fig. 3 : Post surgical pyoderma gangrenosum (a) Before Treatment (b) After treatment with oral prednisolone and mesh-graft transplantation.39